Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 182,790 | 174,116 | 165,423 | 145,678 | 116,178 |
| Receivables | 93,156 | 83,320 | 76,466 | 81,195 | 85,427 |
| Inventories | 15,498 | 15,614 | 17,146 | 18,815 | 15,963 |
| TOTAL | $296,311 | $277,888 | $262,132 | $250,813 | $223,675 |
| Non-Current Assets | |||||
| PPE Net | 19,760 | 18,988 | 17,746 | 15,156 | 13,145 |
| Intangibles | 319,109 | 335,904 | 352,699 | 369,494 | 386,289 |
| Other Non-Current Assets | 10,885 | 11,061 | 11,266 | 11,407 | 11,684 |
| TOTAL | $349,754 | $365,953 | $381,711 | $396,057 | $411,118 |
| Total Assets | $646,065 | $643,841 | $643,843 | $646,870 | $634,793 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 47,705 | 47,495 | 47,281 | 47,069 | 46,859 |
| Accounts payable and accrued liabilities | 8,666 | 10,016 | 6,491 | 8,182 | 6,139 |
| Accrued Expenses | 173,047 | 181,210 | 187,956 | 196,164 | 190,700 |
| TOTAL | $230,168 | $239,451 | $242,437 | $252,111 | $244,374 |
| Non-Current Liabilities | |||||
| Long Term Debt | 98,006 | 110,019 | 121,967 | 133,862 | 145,711 |
| Other Non-Current Liabilities | 147,856 | 108,340 | 106,753 | 105,130 | 103,645 |
| TOTAL | $245,862 | $218,359 | $228,720 | $238,992 | $249,356 |
| Total Liabilities | $476,030 | $457,810 | $471,157 | $491,103 | $493,730 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 35,248 | 34,756 | 34,582 | 34,526 | 34,336 |
| Common Shares | 35 | 35 | 35 | 34 | 34 |
| Retained earnings | -312,197 | -333,147 | -340,105 | -351,391 | -359,449 |
| TOTAL | $170,035 | $186,031 | $172,686 | $155,767 | $141,063 |
| Total Liabilities And Equity | $646,065 | $643,841 | $643,843 | $646,870 | $634,793 |